Average Co-Inventor Count = 3.4

ph-index = 8

Forward Citations = 158(Granted Patents)

Location History:

Nikawa-takadai, Takarazuka-shi, JP (1981)
Nigawatakadai, Takarazuka-shi, Hyogo-ken, JP (1982)
Takarazuka-shi, Hyogo-ken, JP (1985)
Nikawatakadai, Takarazuka, JP (1985)
Hyogo, JP (1978 - 1986)
Takarazuka, JP (1980 - 1987)

Company Filing History:

4 out of 70

Daiichi Seiyaku Co., Ltd.

patents

3 out of 1,858

Takeda Chemical Industries, Inc.

patents

1 out of 6,892

Sumitomo Chemical Company, Limited

patents

4. 1 out of 845

Otsuka Pharmaceutical Company, Limited

patents

5. 4 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1978-1987

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4675291 - Human cultured cell line (1987-06-23),

2. 4606857 - Muramyldipeptide derivatives (1986-08-19),

3. 4544632 - Human T cell lines and method of producing same (1985-10-01),

4. 4543253 - Solidified pharmaceutical composition comprising cell wall skeleton (1985-09-24),

5. 4382080 - Method for treating and preventing bacterial infections (1983-05-03),

6. 4369178 - Glucosamine peptide derivatives, their production and use (1983-01-18),

7. 4330558 - Pharmaceutical composition and method for treating peripheral (1982-05-18),

8. 4317771 - Muramyldipeptide derivatives (1982-03-02),

9. 4314998 - 6-Deoxyglucosamine-peptide derivatives, their production and use (1982-02-09),

10. 4243663 - Glycolipid compositions for transplanted tumor immunotherapy (1981-01-06),

11. 4191778 - Aqueous immunoregulatory agent (1980-03-04),

12. 4101536 - Muramyldipeptide derivatives and process for the preparation thereof (1978-07-18),

Title: Yuichi Yamamura: Innovator in Human Cell Cultures and Immunoadjuvants

Introduction

Yuichi Yamamura is a prominent inventor based in Takarazuka, Japan. He has made significant contributions to the fields of biotechnology and immunology, holding a total of 12 patents. His work focuses on developing novel cultured cell lines and immunoadjuvant compounds that have the potential to advance medical treatments.

Latest Patents

One of his latest inventions is a human cultured cell line derived from human T leukemic cells. This innovative cell line produces a colony-stimulating factor (CSF) and includes a process for preparing the cell line and producing CSF from it. Another notable patent involves muramyldipeptide derivatives, which exhibit excellent immunoadjuvant activity and therapeutic effects against microbial infections and tumors. These compounds are represented by a specific chemical formula and have shown promise in enhancing immune responses.

Career Highlights

Throughout his career, Yuichi Yamamura has worked with various organizations, including Daiichi Seiyaku Co., Ltd. His contributions to the field have been recognized through his numerous patents and innovative research.

Collaborations

Yuichi has collaborated with notable colleagues such as Ichiro Azuma and Tetsuo Shiba, further enhancing the impact of his work in the scientific community.

Conclusion

Yuichi Yamamura's innovative work in human cell cultures and immunoadjuvants showcases his dedication to advancing medical science. His patents reflect a commitment to developing solutions that can improve health outcomes and contribute to the field of biotechnology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.